| Announce Date | 01/29/2026 |
| EPS Normalized Actual | $2.84 (Beat by $0.17) |
| EPS GAAP Actual | $2.84 (Beat by $0.17) |
| Revenue Actual | $102.466B |
| Revenue Surprise | Beat by $102466M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2030 | 0 | INF | 0 | 0 | 10 |
| Sep 2029 | 10.90773 | 25.18 | 10.20626 | 11.77943 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.85 | 1.85 | 102.466B | 7.35% | 102466M |
| FQ2 2025 (Jun 2025) | 1.57 | 1.57 | 94.036B | 8.78% | 94036M |
| FQ1 2025 (Mar 2025) | 1.65 | 1.65 | 95.359B | 4.83% | 95359M |
| FQ4 2024 (Dec 2024) | 2.41 | 2.41 | 124.3B | 3.8% | 124300M |
| FQ3 2024 (Sep 2024) | 0.97 | 0.97 | 94.93B | 13.83% | 94930M |
| FQ2 2024 (Jun 2024) | 1.4 | 1.4 | 85.777B | 100% | 85777M |
| FQ1 2024 (Mar 2024) | 1.53 | 1.53 | 90.753B | 100% | 90753M |
| FQ4 2023 (Dec 2023) | 2.19 | 2.19 | 119.575B | 2.02% | 119575M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 1.91083 | -- | 1.84905 | 1.96307 | 8 |
| FQ1 2028 (Mar 2028) | 2.04991 | -- | 1.98363 | 2.10595 | 8 |
| FQ4 2027 (Dec 2027) | 3.02184 | -- | 2.92414 | 3.10445 | 7 |
| FQ3 2027 (Sep 2027) | 2.11781 | -- | 2.00464 | 2.18869 | 10 |
| FQ2 2027 (Jun 2027) | 1.81841 | -- | 1.72124 | 1.87927 | 16 |
| FQ1 2027 (Mar 2027) | 2.0029 | -- | 1.89587 | 2.06994 | 8 |
| FQ4 2026 (Dec 2026) | 2.93788 | -- | 2.8429 | 3.0182 | 14 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 106.89B | -- | 104.23B | 109.13B | 7 |
| FQ1 2028 (Mar 2028) | 111.31B | -- | 108.54B | 113.65B | 7 |
| FQ4 2027 (Dec 2027) | 146.88B | -- | 143.23B | 149.97B | 8 |
| FQ3 2027 (Sep 2027) | 112.83B | -- | 108.19B | 115.73B | 11 |
| FQ2 2027 (Jun 2027) | 101.49B | -- | 97.32B | 104.1B | 17 |
| FQ1 2027 (Mar 2027) | 107.94B | -- | 103.5B | 110.71B | 9 |
| FQ4 2026 (Dec 2026) | 145.29B | -- | 141.67B | 148.34B | 15 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.85 | 1.85 | 100% | |
| FQ2 2025 (Jun 2025) | 1.57 | 1.57 | 100% | |
| FQ1 2025 (Mar 2025) | 1.65 | 1.65 | 100% | |
| FQ4 2024 (Dec 2024) | 2.41 | 2.41 | 100% | |
| FQ3 2024 (Sep 2024) | 0.97 | 0.97 | 100% | |
| FQ2 2024 (Jun 2024) | 1.4 | 1.4 | 100% | |
| FQ1 2024 (Mar 2024) | 1.53 | 1.53 | 100% | |
| FQ4 2023 (Dec 2023) | 2.19 | 2.19 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $102.47B | $102466M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $94.04B | $94036M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $95.36B | $95359M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $124.3B | $124300M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $94.93B | $94930M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $85.78B | $85777M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $90.75B | $90753M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $119.58B | $119575M | 100% |